{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:18:47Z","timestamp":1788826727250,"version":"build-2803163510"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s13555-022-00851-6","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T16:05:40Z","timestamp":1668096340000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The Combination of Dupilumab with Other Monoclonal Antibodies"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1777-9001","authenticated-orcid":false,"given":"P.","family":"Gisondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maurelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Girolomoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"851_CR1","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/j.1468-3083.2012.04636.x","volume":"26","author":"J Ring","year":"2012","unstructured":"Ring J, Alomar A, Bieber T, European Dermatology Forum; European Academy of Dermatology and Venereology; European Task Force on Atopic Dermatitis; European Federation of Allergy; European Society of Pediatric Dermatology; Global Allergy and Asthma European Network, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol. 2012;26:1176\u201393.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"851_CR2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1001\/jamadermatol.2022.0455","volume":"158","author":"AM Drucker","year":"2022","unstructured":"Drucker AM, Morra DE, Prieto-Merino D, et al. Systemic immunomodulatory treatments for atopic dermatitis: update of a living systematic review and network meta-analysis. JAMA Dermatol. 2022;158:523\u201332.","journal-title":"JAMA Dermatol"},{"key":"851_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.anai.2022.05.015","volume":"129","author":"MM Appiah","year":"2022","unstructured":"Appiah MM, Haft MA, Kleinman E, et al. Atopic dermatitis. Review of comorbidities and therapeutics. Ann Allergy Asthma Immunol. 2022;129:142\u20139.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"851_CR4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/jdv.18008","volume":"36","author":"AL Bosma","year":"2022","unstructured":"Bosma AL, Ascott A, Iskandar R, et al. Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics. J Eur Acad Dermatol Venereol. 2022;36:807\u201319.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"851_CR5","first-page":"3","volume":"33","author":"H Lima","year":"2019","unstructured":"Lima H, Lanzini R, Waserman S. A case series of dupilumab in combination with other biologic therapies in seven patients. J Eur Acad Dermatol Venereol. 2019;33:3.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"851_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13498","volume":"33","author":"R Balestri","year":"2020","unstructured":"Balestri R, Magnano M, Girardelli CR, Bortolotti R, Rech G. Long-term safety of combined biological therapy in a patient affected by arthropathic psoriasis and atopic dermatitis. Dermatol Ther. 2020;33: e13498.","journal-title":"Dermatol Ther"},{"key":"851_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/09546634.2019.1659481","volume":"32","author":"K Barry","year":"2021","unstructured":"Barry K, Zancanaro P, Casseres R, Dumont N, Rosmarin D. A retrospective review of dupilumab and psoriasis biologic combination therapy. J Dermatol Treat. 2021;32:438\u20139.","journal-title":"J Dermatol Treat"},{"key":"851_CR8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/ajd.13676","volume":"62","author":"PD Mahar","year":"2021","unstructured":"Mahar PD, Zubrinich CM, Manuelpillai N, et al. Combination treatment with monoclonal antibodies: secukinumab, benralizumab and dupilumab for the combined management of psoriasis and severe asthma. Australas J Dermatol. 2021;62:506\u20138.","journal-title":"Australas J Dermatol"},{"key":"851_CR9","volume":"11","author":"G Paolino","year":"2022","unstructured":"Paolino G, Di Nicola MR, Brianti P, Bianchi VG, Mercuri SR. New onset atopic dermatitis and psoriasis in the same patients under biologic treatments: the role of systemic treatments as a possible trigger. Dermatol Ther. 2022;11: e15814.","journal-title":"Dermatol Ther"},{"key":"851_CR10","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/cpt.1058","volume":"104","author":"JD Davis","year":"2018","unstructured":"Davis JD, Bansal A, Hassman D, et al. Evaluation of potential disease-mediated drug\u2013drug interaction in patients with moderate-to-severe atopic dermatitis receiving dupilumab. Clin Pharmacol Ther. 2018;104:1146\u201354.","journal-title":"Clin Pharmacol Ther"},{"key":"851_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.36849\/JDD.2020.4722","volume":"19","author":"A Cuellar-Barboza","year":"2020","unstructured":"Cuellar-Barboza A, Zirwas M, Feldman SR. Is dupilumab an immunosuppressant? J Drugs Dermatol. 2020;19:209.","journal-title":"J Drugs Dermatol"},{"key":"851_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","volume":"27","author":"RM Lu","year":"2020","unstructured":"Lu RM, Hwang YC, Liu IJ, et al. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 2020;27:1.","journal-title":"J Biomed Sci"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00851-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00851-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00851-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T18:30:29Z","timestamp":1673029829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00851-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["851"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00851-6","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}